Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-tocopherol and Isotretinoin in Preventing Lung Cancer in Smokers
NCT00003599Phase 3Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 3, randomised trial of vitamin e in lung cancer (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Effect of Alpha-tocopherol (AT) on 13-cis-retinoic Acid (13-cRA) Toxicity at 6 months. Status: withdrawn.
02
Drugs
vitamin e
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00003599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003599.